Using continuous glucose monitoring for patients with colorectal cancer during surgery
Continuous Glucose Monitoring for Colorectal Cancer
This study is testing if continuous glucose monitoring can help doctors understand blood sugar changes during colorectal cancer surgery and see if it can reduce the risk of infections after the operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Gdansk Academic / other |
| Locations | 1 site (Gdańsk, Pomeranian) |
| Trial ID | NCT06011473 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the feasibility of continuous glucose monitoring (CGM) in patients undergoing colorectal cancer surgery. It will measure blood glucose levels continuously to better understand how metabolic stress and surgical interventions affect glycemia. The study will also analyze the relationship between hyperglycemia and the risk of surgical site infections. By utilizing CGM, the research seeks to provide real-time insights into glucose regulation, which could improve postoperative outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with colorectal cancer who are scheduled for surgical intervention.
Not a fit: Patients who are pregnant, undergoing dialysis, or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better glycemic control during and after colorectal cancer surgery, potentially reducing complications and improving recovery.
How similar studies have performed: While continuous glucose monitoring has been used in various contexts, this specific application in colorectal cancer surgery is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * written informed consent * confirmed colorectal cancer qualified for surgery Exclusion Criteria: * patients who will be unable or will refuse to express informed concern * pregnant women * people undergoing dialysis treatment
Where this trial is running
Gdańsk, Pomeranian
- UCC Division of Oncological, Transplant and General Surgery — Gdańsk, Pomeranian, Poland (Recruiting)
Study contacts
- Principal investigator: Magdalena Antoszewska, MD — MUG Division of Dermatology, Venereology and Allergology
- Study coordinator: Magdalena Antoszewska, MD
- Email: magdalena.antoszewska@gumed.edu.pl
- Phone: +48698748705
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.